
==== Front
Front Pain Res (Lausanne)
Front Pain Res (Lausanne)
Front. Pain Res.
Frontiers in Pain Research
2673-561X
2673-561X
Frontiers Media S.A.

10.3389/fpain.2024.1425544
Pain Research
Mini Review
Epidemiology and risk factors for phantom limb pain
Ishigami Shoji 1 2 *

Boctor Carol 2

1 Department of Physical Medicine and Rehabilitation, School of Medicine, West Virginia University, Morgantown, MV, United States
2 School of Medicine, West Virginia University, Morgantown, MV, United States
Edited by: Weibin Shi, Penn State Health, United States

Reviewed by: Natasha Romanoski, The Pennsylvania State University, United States

* Correspondence: Shoji Ishigami shoji.ishigami@wvumedicine.org
21 8 2024
2024
5 142554430 4 2024
06 8 2024
© 2024 Ishigami and Boctor.
2024
Ishigami and Boctor
https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Approximately 356 million limb amputations are performed globally every year. In 2005, the prevalence of limb loss in the United States was 1.6 million people; and it is estimated to increase to 3.6 million by 2050. Many post-amputation patients experience chronically altered sensations and pain associated with the amputation, such as phantom limb pain. The risk factors for phantom limb pain are widely debated in the literature due to the heterogeneity of the population being studied. This review will highlight both the non-operative and operative risk factors for phantom limb pain.

phantom limb pain (PLP)
risk factors
amputation
epidemiology
phantom pain
The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article. section-at-acceptancePain Mechanisms
==== Body
pmcEpidemiology

Approximately 356 million limb amputations are performed globally every year (1). In the United States, the prevalence of limb loss was 1.6 million people in the year 2005; and it is estimated to increase to 3.6 million people by the year 2050 (2). There are about 185,000 amputations performed annually in the U.S. due to vascular disease (82%), trauma (16.4%), cancer (0.9%), and congenital anomalies (0.8%) (3, 4). Amputations are also more common among older individuals, men, and non-white person/persons/people. The total projected lifetime healthcare costs after lower limb amputation were staggering at $509,275 per patient. In addition to accruing that cost, 42% of those patients reported being unable to work for 7 years following their lower limb amputation, further exacerbating the financial and psychological burden (5, 6).

Most of the post-amputee patients experience chronically altered sensations and pain associated with the amputation. Aside from the expected post-surgical pain, these patients can also experience phantom limb pain (PLP), sustained residual stump pain or residual limb pain (RLP), phantom limb sensation (PLS), and telescoping phenomena. In 2020, Stankevicius et al. showed that up to 82% of post-amputees developed PLP within one year from their amputation; and that the lifetime prevalence for PLP and PLS remained equally high (76%–87%, and 87% respectively) (7). They also reported that approximately 25% of amputees experienced telescoping. Another study determined that the prevalence of PLP is estimated to be as low as 64% (8).

Risk factors

This discrepancy in PLP prevalence led to challenges in mitigating the complications of altered sensations. This is largely in part due to the heterogeneity of the population being studied and the historical tendency of physicians to focus more on the non-operative risk factors. However, the PLP risk factors can be divided into 3 categories: pre-operative, peri-operative, and post-operative stages of amputation.

Pre-operative risk factors positively correlated with developing PLP are divided into nonmodifiable and modifiable factors (8–17). Nonmodifiable factors may include age, sex, and race/ethnicity. Modifiable factors can include lack of socioeconomic support, the severity of chronic conditions (ex. diabetes mellitus), preoperative pain levels, absence of pre-procedure counseling, absence of congenital limb loss, and preexisting psychiatric disorders such as anxiety, depression, or tendencies towards catastrophizing. Over the last 8 years, studies displayed some consensus on the two main pre-operative risk factors for PLP (18–20). The first main risk factor is older age. The second is the efficacy of previous pain treatments suggestive of reduced intrinsic capacity for cortical reorganization after amputation.

The risk factors for PLP in the perioperative stage are mainly the surgical techniques utilized during amputation. Emerging evidence suggests that advanced surgical techniques seem to reduce the onset of PLP (21–26). A commonly used surgical technique during amputation is traction neurectomy, in which the nerve is transected under traction and allowed to retract more proximally to the amputated site. This could potentially lead to the formation of a neuroma contributing to RLP. Although only 4.2% of chronic PLP is associated with symptomatic neuromas, Penna et al. and de Lange et al. suggest that advanced surgical techniques seem to reduce the incidence of neuroma and PLP altogether by reconnecting the transected nerve during amputation with another healthy nerve or preserving neuromuscular matrix of the transected nerve (21, 22). In target muscle re-innervation (TMR), a transected mixed or sensory nerve was relocated to nearby or adjacent intact muscles. Then, end-to-end neurorrhaphy with a larger motor terminal end of recipient muscles was performed, reinnervating into the recipient muscles. This allowed the use of muscle contraction signals detectable by electromyography for prosthetic control. Another technique was concomitant nerve coaptation with end-to-end neurorrhaphy of the transected nerves forming a loop wrapped with a collagen nerve wrap (22). In regenerative peripheral nerve interface (RPNI), an autologous muscle graft from the amputated limb was used. The graft was wrapped around the end of the transected nerve and implanted at a location away from the surgical incision site. Of these techniques, TMR and RPNI seem to significantly reduce the incidence of PLP to 0%–56% compared to the control group's 64%–91% (23–26). Although long-term studies with substantially larger sample sizes have not been done for these surgical outcomes, these early results highlight the importance of educating surgeons to reduce the risk of PLP.

The risk factors for PLS in the post-amputation stage are the postsurgical pain, lower limb amputation with shorter residual stump, the intensities of PLS, and telescoping (9, 12, 14, 15, 19). PLP could develop quickly after the amputation; within only 7 days. Of the post-amputation patients, 85% developed PLP (27). Of note, the severity of acute post-surgical pain was found to be a weak predictor for PLP. Conversely, subacute postsurgical pain was determined to be a significant predictor for chronic PLP at 12 months (15). The lower limb amputation and more proximal amputation sites are correlated with a higher incidence of PLP (18). It is still unclear why lower limb amputations have a higher incidence rate compared to upper limb amputations. It could be speculated that maladaptive plasticity (both at the cortical levels and the lumbar spinal circuit) are potential factors. More specifically, the central pattern generators are thought to play a vital role in generating locomotion (28). Interestingly, a study by Dietrich et al. showed that the usage of leg prosthetics with a somatosensory biofeedback system reduced the severity and frequency of PLP (29). Another study by Munger et al. expressed that although the intensity of PLS significantly correlates with PLP, having phantom movement is suggested to be a protective factor against PLP (18).

In conclusion, understanding the risks associated with PLP across all stages of amputation is crucial. Interdisciplinary discussions and education are recommended to mitigate these risks effectively.

Author contributions

SI: Writing – original draft, Writing – review & editing. CB: Writing – review & editing.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
==== Refs
References

1. Moxey PW Gogalniceanu P Hinchliffe RJ Loftus IM Jones KJ Thompson MM Lower extremity amputations–a review of global variability in incidence. Diabet Med. (2011) 28 (10 ):1144–53. 10.1111/j.1464-5491.2011.03279.x 21388445
2. Ziegler-Graham K MacKenzie EJ Ephraim PL Travison TG Brookmeyer R . Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil. (2008) 89 (3 ):422–9. 10.1016/j.apmr.2007.11.005 18295618
3. Dillingham TR Pezzin LE MacKenzie EJ . Limb amputation and limb deficiency: epidemiology and recent trends in the United States. South Med J. (2002) 95 (8 ):875–83. 10.1097/00007611-200208000-00018 12190225
4. Varma P Stineman MG Dillingham TR . Epidemiology of limb loss. Phys Med Rehabil Clin N Am. (2014) 25 (1 ):1–8. 10.1016/j.pmr.2013.09.001 24287235
5. MacKenzie EJ Jones AS Bosse MJ Castillo RC Pollak AN Webb LX Health-care costs associated with amputation or reconstruction of a limb-threatening injury. J Bone Joint Surg Am. (2007) 89 (8 ):1685–92. 10.2106/JBJS.F.01350 17671005
6. MacKenzie EJ Bosse MJ Kellam JF Pollak AN Webb LX Swiontkowski MF Early predictors of long-term work disability after major limb trauma. J Trauma. (2006) 61 (3 ):688–94. 10.1097/01.ta.0000195985.56153.68 16967009
7. Stankevicius A Wallwork SB Summers SJ Hordacre B Stanton TR . Prevalence and incidence of phantom limb pain, phantom limb sensations and telescoping in amputees: a systematic rapid review. Eur J Pain. (2021) 25 (1 ):23–38. 10.1002/ejp.1657 32885523
8. Limakatso K Bedwell GJ Madden VJ Parker R . The prevalence and risk factors for phantom limb pain in people with amputations: a systematic review and meta-analysis. PLoS One. (2020) 15 (10 ):e0240431. 10.1371/journal.pone.0240431 33052924
9. Griffin SC Alphonso AL Tung M Finn S Perry BN Hill W Characteristics of phantom limb pain in U. S. civilians and service members. Scand J Pain. (2022) 22 (1 ):125–32. 10.1515/sjpain-2021-0139 34529903
10. Noguchi S Saito J Nakai K Kitayama M Hirota K . Factors affecting phantom limb pain in patients undergoing amputation: retrospective study. J Anesth. (2019) 33 (2 ):216–20. 10.1007/s00540-018-2599-0 30603827
11. Jensen MP Ehde DM Hoffman AJ Patterson DR Czerniecki JM Robinson LR . Cognitions, coping and social environment predict adjustment to phantom limb pain. Pain. (2002) 95 (1-2 ):133–42. 10.1016/S0304-3959(01)00390-6 11790476
12. Limakatso K Ndhlovu F Usenbo A Rayamajhi S Kloppers C Parker R . The prevalence and risk factors for phantom limb pain: a cross-sectional survey. BMC Neurol. (2024) 24 (1 ):57. 10.1186/s12883-024-03547-w 38321380
13. Gallagher P Allen D Maclachlan M . Phantom limb pain and residual limb pain following lower limb amputation: a descriptive analysis. Disabil Rehabil. (2001) 23 (12 ):522–30. 10.1080/09638280010029859 11432649
14. Ephraim PL Wegener ST MacKenzie EJ Dillingham TR Pezzin LE . Phantom pain, residual limb pain, and back pain in amputees: results of a national survey. Arch Phys Med Rehabil. (2005) 86 (10 ):1910–9. 10.1016/j.apmr.2005.03.031 16213230
15. Larbig W Andoh J Huse E Stahl-Corino D Montoya P Seltzer Z Pre- and postoperative predictors of phantom limb pain. Neurosci Lett. (2019) 702 :44–50. 10.1016/j.neulet.2018.11.044 30503915
16. Raichle KA Osborne TL Jensen MP Ehde DM Smith DG Robinson LR . Preoperative state anxiety, acute postoperative pain, and analgesic use in persons undergoing lower limb amputation. Clin J Pain. (2015) 31 (8 ):699–706. 10.1097/AJP.0000000000000150 26153780
17. Fuchs X Flor H Bekrater-Bodmann R . Psychological factors associated with phantom limb pain: a review of recent findings. Pain Res Manag. (2018) 2018 :5080123. 10.1155/2018/5080123 30057653
18. Munger M Pinto CB Pacheco-Barrios K Duarte D Enes Gunduz M Simis M Protective and risk factors for phantom limb pain and residual limb pain severity. Pain Pract. (2020) 20 (6 ):578–87. 10.1111/papr.12881 32176435
19. Diers M Krumm B Fuchs X Bekrater-Bodmann R Milde C Trojan J The prevalence and characteristics of phantom limb pain and non-painful phantom phenomena in a nationwide survey of 3,374 unilateral limb amputees. J Pain. (2022) 23 (3 ):411–23. 10.1016/j.jpain.2021.09.003 34583023
20. Yin Y Zhang L Xiao H Wen CB Dai YE Yang G The pre-amputation pain and the postoperative deafferentation are the risk factors of phantom limb pain: a clinical survey in a sample of Chinese population. BMC Anesthesiol. (2017) 17 (1 ):69. 10.1186/s12871-017-0359-6 28549447
21. Penna A Konstantatos AH Cranwell W Paul E Bruscino-Raiola FR . Incidence and associations of painful neuroma in a contemporary cohort of lower-limb amputees. ANZ J Surg. (2018) 88 (5 ):491–6. 10.1111/ans.14293 29654613
22. de Lange JWD Hundepool CA Power DM Rajaratnam V Duraku LS Zuidam JM . Prevention is better than cure: surgical methods for neuropathic pain prevention following amputation - A systematic review. J Plast Reconstr Aesthet Surg. (2022) 75 (3 ):948–59. 10.1016/j.bjps.2021.11.076 34955394
23. Valerio IL Dumanian GA Jordan SW Mioton LM Bowen JB West JM Preemptive treatment of phantom and residual limb pain with targeted muscle reinnervation at the time of major limb amputation. J Am Coll Surg. (2019) 228 (3 ):217–26. 10.1016/j.jamcollsurg.2018.12.015 30634038
24. O'Brien AL Jordan SW West JM Mioton LM Dumanian GA Valerio IL . Targeted muscle reinnervation at the time of upper-extremity amputation for the treatment of pain severity and symptoms. J Hand Surg Am. (2021) 46 (1 ):72.e1–72.e10. 10.1016/j.jhsa.2020.08.014
25. Frantz TL Everhart JS West JM Ly TV Phieffer LS Valerio IL . Targeted muscle reinnervation at the time of major limb amputation in traumatic amputees: early experience of an effective treatment strategy to improve pain. JB JS Open Access. (2020) 5 (2 ):e0067. 10.2106/JBJS.OA.19.00067 33123667
26. Economides JM DeFazio MV Attinger CE Barbour JR . Prevention of painful neuroma and phantom limb pain after transfemoral amputations through concomitant nerve coaptation and collagen nerve wrapping. Neurosurgery. (2016) 79 (3 ):508–13. 10.1227/NEU.0000000000001313 27306717
27. Flahaut M Laurent NL Michetti M Hirt-Burri N Jensen W Lontis R Patient care for postamputation pain and the complexity of therapies: living experiences. Pain Manag. (2018) 8 (6 ):441–53. 10.2217/pmt-2018-0033 30175653
28. Minassian K Bayart A Lackner P Binder H Freundl B Hofstoetter US . Rare phenomena of central rhythm and pattern generation in a case of complete spinal cord injury. Nat Commun. (2023) 14 (1 ):3276. 10.1038/s41467-023-39034-y 37280242
29. Dietrich C Nehrdich S Seifert S Blume KR Miltner WHR Hofmann GO Leg prosthesis with somatosensory feedback reduces phantom limb pain and increases functionality. Front Neurol. (2018) 9 :270. 10.3389/fneur.2018.00270 29755399
